|1|Histopathological characteristics of breast ductal carcinoma in situ and association with imaging findings. (25644245)
Tang X.... Masuda S.
|2|Paget's disease of the male breast with underlying ductal carcinoma in situ ('DCIS'). (25832464)
Choudhury B.... Bright-Thomas R.
|3|Inter-observer variability between general pathologists and a specialist in breast pathology in the diagnosis of lobular neoplasia, columnar cell lesions, atypical ductal hyperplasia and ductal carcinoma in situ of the breast. (24948027)
Gomes D.S.... Gobbi H.
|4|Molecular Pathology: SY18-1 MOLECULAR PROFILING OF BREAST DUCTAL CARCINOMA IN-SITU. (25188123)
Agosto-Arroyo E.... Harada S.
|5|Post-operative radiotherapy for ductal carcinoma in situ of the breast. (24259251)
Goodwin A.... Wilcken N.
|6|Hypofractionated radiation therapy for breast ductal carcinoma in situ. (24113057)
Hathout L.... Yassa M.
|7|Patient, tumor and therapeutic features related to recurrence of ductal carcinoma in situ (DCIS). (24322025)
|8|Elevated lipogenesis in epithelial stem-like cell confers survival advantage in ductal carcinoma in situ of breast cancer. (23208501)
Pandey P.R.... Watabe K.
|9|US appearance of ductal carcinoma in situ. (23322838)
Wang L.C.... Mendelson E.B.
|10|Clinicopathologic features of ductal carcinoma in situ in young women with an emphasis on molecular subtype. (24029706)
VandenBussche C.J.... Warzecha H.N.
|11|Factors influencing the quality of local management of ductal carcinoma in situ: a cohort study. (23737691)
Krotneva S.P.... Meguerditchian A.N.
|12|Near-infrared fluorescence molecular imaging of ductal carcinoma in situ with CD44v6-specific antibodies in mice: a preclinical study. (23184608)
Vermeulen J.F.... Derksen P.W.
|13|Challenging paradigms: long non-coding RNAs in breast ductal carcinoma in situ (DCIS). (23577021)
Kosir M.A.... Lipovich L.
|14|Molecular phenotypes of ductal carcinoma-in-situ and invasive ductal carcinoma: a comparative study. (22499299)
Gupta S.... Singh S.
|15|Neuroendocrine ductal carcinoma in situ, comedo type, of the breast detected by screening mammography: a potentially pre-invasive counterpart of high grade neuroendocrine tumours. (22437750)
Kawasaki T.... Katoh R.
|16|Multi-institutional experience of ductal carcinoma in situ in black vs white patients treated with breast-conserving surgery and whole breast radiation therapy. (22672752)
Nelson C.... Moran M.S.
|17|Predictors of invasive breast cancer and lymph node involvement in ductal carcinoma in situ initially diagnosed by vacuum-assisted breast biopsy: experience of 733 cases. (22795363)
Trentin C.... Cassano E.
|18|Progression of ductal carcinoma in situ to invasive breast cancer is associated with gene expression programs of EMT and myoepithelia. (22134623)
Knudsen E.S.... Witkiewicz A.K.
|19|ACR appropriateness criteria(Ar) ductal carcinoma in situ. (22107336)
Moran M.S.... Haffty B.G.
|20|Cell polarity, epithelial-mesenchymal transition, and cell-fate decision gene expression in ductal carcinoma in situ. (22577534)
Coradini D.... Oriana S.
|21|Breast cancer and ductal carcinoma in situ among women with prior squamous or glandular precancer in the cervix: a register-based study. (23011481)
Hansen B.T.... Hofvind S.
|22|Effect of tamoxifen and radiotherapy in women with locally excised ductal carcinoma in situ: long-term results from the UK/ANZ DCIS trial. (21145284)
Cuzick J.... George W.D.
|23|Development and pilot testing of a communication aid to assist clinicians to communicate with women diagnosed with ductal carcinoma in situ (DCIS). (21088858)
De Morgan S.E.... Nehill C.
|24|Intraoperative assessment of surgical margins during breast conserving surgery of ductal carcinoma in situ by use of radiofrequency spectroscopy. (21885281)
Thill M.... Dittmer C.
|25|Tissue microarray-based immunohistochemical study can significantly underestimate the expression of HER2 and progesterone receptor in ductal carcinoma in situ of the breast. (20701550)
Lin Y.... Tang P.
|26|Ductal carcinoma in situ at core-needle biopsy: meta-analysis of underestimation and predictors of invasive breast cancer. (21493791)
Brennan M.E.... Houssami N.
|27|Mammographycally occult high grade ductal carcinoma in situ (DCIS) as second primary breast cancer, detected with MRI: a case report. (22933920)
Zebic-Sinkovec M.... Snoj M.
|28|Vasohibin-1 as a potential predictor of aggressive behavior of ductal carcinoma in situ of the breast. (20704578)
Tamaki K.... Ohuchi N.
|29|Changes in invasive breast cancer and ductal carcinoma in situ rates in relation to the decline in hormone therapy use. (21060026)
Farhat G.N.... Kerlikowske K.
|30|Ductal carcinoma in situ: terminology, classification, and natural history. (20956817)
|31|Proceedings of the National Institutes of Health State-of-the-Science Conference, Diagnosis and Management of Ductal Carcinoma In Situ. September 2009. (21312388) |2010|
|32|Coronal serial sequential sampling of breast specimen in the assessment of the extent of ductal carcinoma in situ. (19722734)
Mai K.T.... Burns B.F.
|33|P63 and cytokeratin8/18 expression in breast, atypical ductal hyperplasia, ductal carcinoma in situ and invasive duct carcinoma. (19190693)
Shamloula M.M.... Saied E.M.
|34|Ductal carcinoma in situ in BRCA mutation carriers. (17210933)
Hwang E.S.... Ziegler J.L.
|35|Expression of MT-1 MMP, MMP2, MMP9 and TIMP2 mRNAs in ductal carcinoma in situ and invasive ductal carcinoma of the breast. (16807982)
Kim H.J.... Jung W.H.
|36|Cytokeratins in papillary lesions of the breast: is there a role in distinguishing intraductal papilloma from papillary ductal carcinoma in situ? (15832086)
Tan P.H.... Tse G.M.
|37|Incidence and clinical significance of lymph node metastasis detected by cytokeratin immunohistochemical staining in ductal carcinoma in situ. (15827818)
El-Tamer M.... Mansukhani M.
|38|S100A7 (psoriasin) expression is associated with aggressive features and alteration of Jab1 in ductal carcinoma in situ of the breast. (15217497)
Emberley E.D.... Watson P.H.
|39|p14ARF expression in invasive breast cancers and ductal carcinoma in situ--relationships to p53 and Hdm2. (15318938)
Vestey S.B.... Winters Z.E.
|40|Cyclooxygenase-2 expression: a potential prognostic and predictive marker for high-grade ductal carcinoma in situ of the breast. (14717665)
Tan K.B.... Putti T.C.
|41|Evaluation of MUC1 splice variants as prognostic markers in patients with ductal carcinoma in situ of the breast. (14534730)
Schmid B.C.... Zeillinger R.
|42|Angiogenesis, thrombospondin, and ductal carcinoma in situ of the breast. (12147647)
Rice A.... Quinn C.M.
|43|Immunohistochemical expression of uPA, PAI-1, cathepsin D and apoptotic cells in ductal carcinoma in situ of the breast. (12016391)
Zhao H.... Izumi K.
|44|Cyclooxygenase-2 expression in human breast cancers and adjacent ductal carcinoma in situ. (11912139)
Half E.... Sinicrope F.A.
|45|Usual ductal hyperplasia of the breast is a committed stem (progenitor) cell lesion distinct from atypical ductal hyperplasia and ductal carcinoma in situ. (12434415)
Boecker W.... Buchwalow I.B.
|46|p53 missense mutations in microdissected high-grade ductal carcinoma in situ of the breast. (11333292)
Done S.J.... Andrulis I.L.
|47|Apocrine ductal carcinoma in situ of the breast: histologic classification and expression of biologic markers. (11381366)
Leal C.... Page D.L.
|48|Atypical cystic lobule of the breast: an early stage of low-grade ductal carcinoma in-situ. (11114859)
Oyama T.... Koerner F.
|49|Amplification of CCND1 and expression of its protein product, cyclin D1, in ductal carcinoma in situ of the breast. (9212742)
Simpson J.F.... Clarke P.E.
|50|Controversies in the treatment of ductal carcinoma in situ. (8610262)
Hughes K.S.... Rolfs A.